Dr. Dean Kereiakes and Dr. C. Michael Gibson Discuss: RUC-4, a novel small molecule Platelet GPIIb/IIIa inhibitor designed for subcutaneous point of first contact STEMI treatment September 9, 2020 2020 | Cardiology | STEMI Tags: 2020, Cardiology, STEMI Article Navigation Dr. Burkert Pieske and Dr. C. Michael Gibson Discuss: PARALLAX: Sacubitril/Valsartan versus Individualized RAAS Blockade in Patients with HFpEF Dr. Roxana Mehran and Dr. C. Michael Gibson Discuss: The Second Wave of COVID in New York Cit
